Lomerizine also reduced tumor volume and prolonged overall survival in vivo. Based on our data from in vitro and in vivo experiments, lomerizine has potential as a novel GBM therapeutic agent targeting against both GICs and differentiated glioma cells and could benefit for GBM patients.

Among the tested compounds, Tetrandrine, Dauricine, and Olmutinib exhibited robust binding affinities across both wild-type and mutant EGFR configurations, highlighting their potential as effective inhibitors. The integrated approach of combining molecular docking using CB-dock2, ADMET profiling, and Lipinski's rule of five provides a robust framework for preliminary drug candidate screening, potentially accelerating the development of more precise and effective EGFR-targeted therapies. The findings contribute to the growing body of research exploring alternative and more nuanced strategies for inhibiting EGFR-driven oncogenic mechanisms, highlighting the importance of computational methods in identifying novel molecular targets with improved specificity and reduced side effects.

P1/2, N=24, Recruiting, Amsterdam UMC | Not yet recruiting --> Recruiting

P=N/A, N=140, Recruiting, The University of Hong Kong

P1/2, N=60, Not yet recruiting, Mayo Clinic

P4, N=140, Completed, Haseki Training and Research Hospital

Cav1.3 inhibitors including isradipine and cp-PYT significantly reduced apoptosis and improved mDAN survival in both interferon gamma (IFN-γ)- and tumor necrosis factor alpha (TNF-α)-induced inflammatory models, as well as in the 6-OHDA-induced toxic model in vitro...Moreover, we showed that cp-PYT treatment enhanced mDAN survival while reducing mature graft volume post-transplantation. Therefore, Cav1.3 inhibition may represent a clinically relevant strategy to enhance the survival of human pluripotent stem cell (hPSC)-derived mDANs in cell therapy for PD.

P3, N=50, Completed, Laboratorios Richmond S.A.C.I.F.

P2, N=138, Active, not recruiting, Medical University of Graz | Not yet recruiting --> Active, not recruiting

In a collaborative initiative to document and scientifically validate this knowledge, the Tropical Indigenous Ethnobotany Centre, Australian Tropical Herbarium and the James Cook University have been working closely with traditional custodians from the Iningai community near Barcaldine, Queensland...The identification of key phytochemicals, antioxidant potential and anti-inflammatory properties supports their ethnopharmacological relevance. Further investigation is warranted to isolate and characterise the active compounds from the most promising species for potential development into novel therapeutic agents.

P=N/A, N=40, Not yet recruiting, Western Sydney Local Health District